doxorubicin hydrochloride

Sagent Pharmaceuticals🇺🇸 United States

FDA Page

Effective Date: May 18, 2023
Approval ID: ae80bd3a-b99a-4e01-a444-b9d05687f00e
Products: 1 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE INJECTION. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.